Abstract
Because of the high risk of recurrence following surgery for squamous cell carcinomas of the esophagus, treatment involving both systemic therapy and a localized approach [either surgery alone or chemo/radiation and surgery] have been extensively studied. Pilot trials have demonstrated safety for the use of chemotherapy followed by operation, or for chemotherapy plus standard radiation plus surgery. Larger scale phase III trials, in which either of these two strategies is employed, have now been reported. For chemotherapy followed by surgery, conflicting results have recently been noted. A US intergroup trial showed no significant outcome for all patients treated. A smaller European study, also using a cisplatin-based regimen, had a positive result. Similarly, for chemoradiation followed by operation, two recent random assignment studies failed to demonstrate a significant difference in outcome. However, recently newer chemotherapy agents have been identified which hold promise for more effective therapy. These include paclitaxel and irinotecan. Phase II trials, using these agents prior to surgery, are underway or have been completed, and phase III studies are in the advanced planning stage. Until these trials have demonstrated superiority, surgery alone or chemoradiation without surgery remain the standard of care, for patients with esophageal cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Blot WJ, Devesa SS, Kneller RW, Fraumeni JF (1991) Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265: 1287–1289
Yokes EE (1993) Interactions of chemotherapy and radiation. Semin Oncol 20: 70–79
Steel GG, Peckham MJ (1979) Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Onc Biol Phys 5: 85–91
Lightdale C, Botet J, Brennan M et al (1989) Endoscopic ultrasonography compared to computerized tomography for preoperative staging of gastric cancer. Gastrointest Endosc 35: 154 (abstract)
Tio TL, Coene PP, Luiken GJ, Tytgat GN (1990) Endosonography in the clinical staging of esophagogastric carcinoma. Gastrointest Endosc 36: s2–s10
Kelsen D, Ajani J, Ilson D, Daugherty K, Pazdur R (1994) A phase II trial of paclitaxel (Taxol) in advanced esophageal cancer: preliminary report. Semin Oncol 21: 44–48
Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S (1988) Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 96: 242–248
Kelsen DP, Minsky B, Smith M et al (1990) Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy. J Clin Oncol 8: 1352–1361
Nygaard K, Hagen S, Hansen HS et al (1992) Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 16: 1104–1110
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kelsen, D.P. (2000). Neoadjuvant Therapy of Squamous Cell Carcinoma of the Esophagus. In: Lange, J., Siewert, J.R. (eds) Esophageal Carcinoma. Recent Results in Cancer Research, vol 155. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59600-1_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-59600-1_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64044-5
Online ISBN: 978-3-642-59600-1
eBook Packages: Springer Book Archive